BRAINSTORM CELL THERAPEUTICS INC. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Brainstorm Cell Therapeutics Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Brainstorm Cell Therapeutics Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $166K, a 57% decline year-over-year.
  • Brainstorm Cell Therapeutics Inc. annual Operating Lease, Payments for 2023 was $1.31M, a 14.6% decline from 2022.
  • Brainstorm Cell Therapeutics Inc. annual Operating Lease, Payments for 2022 was $1.54M, a 44.4% decline from 2021.
  • Brainstorm Cell Therapeutics Inc. annual Operating Lease, Payments for 2021 was $2.77M, a 94.4% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $166K -$220K -57% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $386K -$291K -43% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $2.76M $677K -$7K -1.02% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $2.77M $709K Oct 1, 2021 Dec 31, 2021 10-K 2022-03-28
Q3 2021 $690K Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $684K Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $684K +$357K +109% Jan 1, 2021 Mar 31, 2021 10-Q 2021-04-26
Q1 2020 $327K +$10K +3.16% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-07
Q1 2019 $317K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.